Albany, NY -- (SBWIRE) -- 03/16/2019 -- According to the National Institutes of Health, the worldwide number of patients with chronic kidney disease is rising rapidly and is expected to rise by approximately 5% to 8% annually. Increasing prevalence of diabetes and hypertension are the two primary causes of end stage renal disease in major developing countries like China, Brazil and India and is also contributing to the growth of overall dialysis products and services market.
According to the American Kidney Fund, diabetes and hypertension are responsible for 38.4% and 25% of all cases of kidney failures, respectively. Similarly, increasing geriatric population and low preference by patients above 65 years of age to opt for kidney transplant is also driving the growth of dialysis products and services market. According to the Australian Institute of Health and Welfare, the proportion of people opting for kidney transplantation decreases with age. Moreover, increasing awareness about peritoneal dialysis is expected to boost the growth of the market in the near future.
The global dialysis products and services market is segmented by type of procedures and type of services. The procedures market is further segmented into hemodialysis and peritoneal dialysis. Further, the hemodialysis segment (HD) is classified into HD machine, dialyzer, access products/catheters, bloodlines, concentrates and others, which include water treatment systems and fistula needles. Hemodialysis, being the oldest and most preferred technique for dialysis procedure, Hemodialysis machines captures the largest share, of the total market in 2013.
Request A Sample-
The segment is expected to lead the market during the forecast period from 2014 to 2020. Similarly, peritoneal dialysis (PD) segment is classified into concentrates/dialysate, PD machines, catheters, and transfer sets. Among these, the PD concentrates/dialysate segment is accounted for largest market share in 2013 and is expected to grow at an attractive higher growth rate during the forecast period from 2014 to 2020. The major factors responsible for the significant growth of this segment are increase in the number of patients preferring peritoneal dialysis, and rising demand of patients to be dialyzed overnight with the aid of peritoneal dialysis.
Based on the type of services, the global dialysis products and services market is classified into in-center dialysis and home dialysis, in which in-center dialysis is the most commonly preferred service. In-center dialysis would continue to dominate the largest market share due to high demand of patients to be dialyzed on a fixed schedule in a dialysis center by trained healthcare experts. Similarly, in terms of growth, home dialysis segment is expected to grow rapidly in the overall dialysis products and services market. The rationale behind such growth is attributed to increasing flexibility and control over the dialysis treatment performed at home.
Geographically, North America constituted the largest share for dialysis products and services market in 2013. Factors such as high prevalence of end stage renal disease, availability of favorable reimbursement policies and rapid adoption of technologically advanced and innovative dialysis products and services are responsible for the high market share of North America. In addition, development of the healthcare infrastructure and increasing willingness and affordability of the patient population to spend on newer and advanced dialysis treatment would most likely fuel the growth of the market. However, Asia Pacific is predicted to foresee the highest growth rate in the near future. The rationale behind such growth has been attributed to favorable government policies, fast growing consumer market and increasing adoption of novel technologies. Moreover, presence of skilled labor, easy market penetration and tax benefits would propel the growth of the global dialysis products and services market in the next few years.
Major players dominating the global dialysis products and services market include Fresenius SE & Co. KGaA, DaVita Healthcare Partners, Inc., Baxter International, Inc., Nikkiso Co., Ltd. and Nipro Corporation. Other players in this market include C.R. Bard, Inc., Cantel Medical Corporation, Medical Components, Inc., Covidien plc, Asahi Kasei Medical Co., Ltd., B. Braun Medical, Kawasumi Laboratories, NxStage Medical, Inc. and Rockwell Medical Technologies, Inc.